PET
PSMA
hepatocellular carcinoma
staging
theranostic
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
received:
02
10
2020
accepted:
28
12
2020
pubmed:
30
1
2021
medline:
7
1
2022
entrez:
29
1
2021
Statut:
ppublish
Résumé
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. A growing number of local and systemic therapies are available, and accurate staging is critical for management decisions. We assessed the impact of neovasculature imaging by
Identifiants
pubmed: 33509970
pii: jnumed.120.257915
doi: 10.2967/jnumed.120.257915
pmc: PMC8882890
doi:
Substances chimiques
Gallium Isotopes
0
Gallium Radioisotopes
0
gallium 68 PSMA-11
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1235-1241Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Références
J Hepatol. 2018 Aug;69(2):336-344
pubmed: 29518452
Ann Oncol. 2012 Oct;23 Suppl 7:vii41-8
pubmed: 22997453
Cancers (Basel). 2019 Jun 18;11(6):
pubmed: 31216701
Oncologist. 2010;15 Suppl 4:42-52
pubmed: 21115580
J Nucl Med. 2018 Jul 12;60(2):185-191
pubmed: 30002112
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
JAMA Oncol. 2019 Jun 1;5(6):856-863
pubmed: 30920593
Cancer Imaging. 2017 Mar 4;17(1):9
pubmed: 28259177
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Lancet. 2012 Mar 31;379(9822):1245-55
pubmed: 22353262
Chin Clin Oncol. 2018 Oct;7(5):50
pubmed: 30395717
Lancet Oncol. 2009 Jan;10(1):25-34
pubmed: 19095497
Eur Urol. 2020 Apr;77(4):403-417
pubmed: 30773328
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):883-892
pubmed: 32885272
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255
pubmed: 30285213
Expert Rev Med Devices. 2019 May;16(5):341-350
pubmed: 30990129
Radiology. 2014 Sep;272(3):635-54
pubmed: 25153274
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Hepatology. 2018 Jan;67(1):401-421
pubmed: 28859233
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Curr Probl Diagn Radiol. 2015 Nov-Dec;44(6):479-86
pubmed: 25979220
Cancers (Basel). 2019 Jun 17;11(6):
pubmed: 31212948
Cancer Res. 1999 Jul 1;59(13):3192-8
pubmed: 10397265
Oncotarget. 2019 Jun 25;10(41):4149-4160
pubmed: 31289613
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Ther Clin Risk Manag. 2016 Mar 16;12:445-55
pubmed: 27042086
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Clin Cancer Res. 1999 Oct;5(10):2674-81
pubmed: 10537328
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846